http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d339d319374356ab6e49b5d0adb6318b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Johnston |
| name | James A. Johnston James A Johnston |
| given-name | James A. James A |
| organization-name | Department of Discovery Research, DNAX Research Inc., Palo Alto, California 94304 ‡School of Medicine, Centre of Infection and Immunity, Queens University Belfast, Belfast BT9 7AE, United Kingdom;; §Inflammation Research, Amgen Inc., Thousand Oaks, CA 91320; ‡DNAX Research Institute, Palo Alto, CA 94304; Institutes of The Lymphocyte Cell Biology Section, National Institute of Arthritis, Musculoskeletal and Skin Disease, National Institutes of Health , Bethesda, Maryland *Department of Microbiology and Immunology, Queen’s University of Belfast, Belfast, Northern Ireland; and Amgen Research, Thousand Oaks, CA 91320, USA. 2Centre for Cancer Research and Cell Biology, Queen's University of Belfast; and DNAX Palo Alto California Molecular Immunology Kerckhoff Laboratories of Biology, California Institute of Technology, Pasadena, California *Centre for Infection and Immunity, Queen’s University Belfast, Belfast BT9 7AE, Northern Ireland; Department of Microbiology and Immunology, Queen’s University , Belfast , Northern Ireland Enfer Scientific, Unit T, M7 Business Park, Newhall, Naas, County Kildare, Ireland; Fusion Antibodies Ltd., Unit 4, Springbank Industrial Estate, Pembroke Loop Rd., BT17 0QL, Northern Ireland; Quansys Biosciences, 365 North 600 West, Logan, Utah 84321; Central Veterinary Research Laboratory, Backweston, County Dublin, Ireland; Department of Agriculture and Food, Kildare St., Dublin 2, Ireland Infection and Immunity Group, Centre for Cancer Research and Cell Biology, Queens University, Belfast, United Kingdom; Infection and Immunity, Cancer Research and Cell Biology, School of Biomedical Science , Belfast , Northern Ireland §Department of Microbiology and Immunobiology, Queen’s University of Belfast, Belfast, North Ireland 4Department of Immunology, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland *Centre for Infection and Immunity, Queen’s University Belfast, Belfast, Northern Ireland, United Kingdom; and Infection and Immunity Group, Centre for Cancer Research and Cell Biology, Queens University, 97 Lisburn Rd., Belfast BT9 7BL, United Kingdom From the DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA, and the Division of Pediatric Oncology and Cellular and Molecular Biology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA. Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Health Sciences Building, 97 Lisburn Road, Belfast BT9 7BL, U.K. DNAX Research Institute, 901 California Avenue, Palo Alto, CA 94304; Institut de Genetique Moleculaire de Montpellier, Montpellier, France; Department of Cancer Biology, Cleveland Clinic Foundation Research Institute, Cleveland OH 44195; Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda MD 20892 School of Medicine, Dentistry and Biomedical Sciences Queen's University Belfast Lisburn Road Belfast BT9 7BL United Kingdom; Inflammation Research, Amgen Inc, One Amgen Center Drive Thousand Oaks CA 91320 Centre for Infection and Immunity, Queen's University Belfast, Belfast, Northern Ireland, UK; Current address: Amgen, One Amgen Center Dr., Thousand Oaks, CA DNAX Research Institute, Palo Alto, California 94304 Laboratory of Immunoregulation, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research and Development Center ; Frederick, Maryland Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Science, Queen's University of Belfast , Northern Ireland Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast BT9 7AE, UK.; Inflammation Research, Amgen Inc., Thousand Oaks, CA 91320, USA. *Cell Signaling and Authors' Affiliations: 1School of Pharmacy, 2Centre for Infection and Immunity, and 3Institute of Pathology, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, and 4Fusion Antibodies Ltd., Springbank Industrial Estate, Belfast, United Kingdom; Authors' Affiliations: 1School of Pharmacy, 2Centre for Infection and Immunity, and 3Institute of Pathology, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, and 4Fusion Antibodies Ltd., Springbank Industrial Estate, Belfast, United Kingdom Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, U.K. Leukocyte Cell Biology Section, Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick, MD 21702-1201, USA. The Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast BT9 7BL, Northern Ireland 1 Infection and Immunity Group, Centre for Cancer Research and Cell Biology, School of Biomedical Sciences, Faculty of Medicine, Health and Life Sciences, Queen's University, Whitla Medical Building, Belfast BT9 7BL, N. Ireland, U.K. *Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast BT9 7AE, Northern Ireland, United Kingdom; Authors' Affiliations: 1Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences; 2Molecular Therapeutics, School of Pharmacy, Faculty of Medicine, Health and Life Sciences, Queen's University Belfast, Belfast, United Kingdom Infection and Immunity, Centre for Cancer Research and Cell Biology, Queens University, Belfast, United Kingdom; Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Health Sciences Building, Belfast, UK; Current address, Inflammation Research, Amgen Inc., Thousand Oaks, CA From the Clinical Gene Therapy Branch, National Center for Human Genome Research; the Leukocyte Cell Biology Section, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD; the Department of Pediatrics, University of Brescia, Brescia, Italy; and the Istituto di Tecnologie Biomediche Avanzate, CNR, Milan, Italy. Fusion Antibodies Ltd., Springbank Ind. Est. Belfast, Northern Ireland BT17 0QL. |
Incoming Links
Total number of triples: 140.